Literature DB >> 29022736

Preliminary evaluation of treatment outcomes at a military intensive outpatient program.

Tim Hoyt1, David Barry2, So Heui Kwon2, Claire Capron2, Noriko De Guzman2, James Gilligan2, Amanda Edwards-Stewart1.   

Abstract

Recent U.S. Army policy has established intensive outpatient programs at several installations as part of a comprehensive behavioral health system of care. This study presents retrospective program evaluation data from a case series without randomization or a control group at 1 recently established intensive outpatient program for active duty service members at a joint military installation. Out of 240 patients referred to the program at 1 installation, 200 enrolled in treatment. Of these, 169 completed treatment in a Skills & Resiliency Track (n = 97), Trauma Track (n = 34), or both (Combined Track; n = 38). Patients completed measures of posttraumatic stress symptoms and general distress throughout program enrollment. First year preliminary results show significant decreases in distress for those in the Skills & Resiliency and Combined groups. Trauma group patients showed significant decreases in posttraumatic stress symptoms. Patients in the Skills & Resiliency and Combined groups showed significant decreases in rates of psychiatric hospitalization. These results show potential for treating high-risk or treatment-resistant patients in a half-day intensive outpatient program. Lessons learned and recommendations for establishing intensive outpatient programming for the military are discussed. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 29022736     DOI: 10.1037/ser0000190

Source DB:  PubMed          Journal:  Psychol Serv        ISSN: 1541-1559


  1 in total

1.  A case analysis of service-member trauma processing related to art therapy within a military-intensive outpatient program.

Authors:  Brenda Maltz; Tim Hoyt; Jay Uomoto; Megan Herodes
Journal:  J Clin Psychol       Date:  2020-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.